Treatment and Care for Drug Users Living with HIV/AIDS. Oppenheimer E, Aceijas CH and Stimson G (2003)

Treatment and Care for Drug Users Living with HIV/AIDS. Oppenheimer E, Aceijas CH and Stimson G (2003) This report has been prepared in October-April 2004 by the Centre for Research on Drugs and Health Behaviours at Imperial College on behalf of the UN Reference on HIV/AIDS prevention and care among IDUs in developing and transitional countries. Its purpose is to examine the extent to which the international community’s commitment to adequate and equitable care for those with HIV/AIDS has been translated into action in developing and transitional countries particularly when applied to injecting drug users1. The provision of effective treatment and care for all people with HIV/AIDS is now accepted as an integral component of a comprehensive and expanded response to the epidemic. All member states of the United Nations and partner international agencies are committed to reducing the gap between developed and developing countries and making treatment and care available to all who require it.

Download this publication

Behavioral and Sero Prevalence Survey among Injecting Drug Users (IDUs) in Kathmandu. New ERA and STD/AIDS Counseling and Training Service, FHI, et al (2002)

Lao PDR 2009 Surveillance Surveys: Behavioral Survey among Service Women and Integrated Biological and Behavioral Surveillance Survey among Men who have Sex with Men in Luang Prabang. Center for HIV/AIDS/STI Lao (2009)

HIV transmission among drug users is typically associated with injecting drug users who oftentimes share needles or syringes. Risky behavior has been defined here as needle sharing behaviors, unprotected sex with various partners or sex workers. Risky sexual behavior associated with the drug use also contributes to spread HIV.

 

 

Download this publication

 

Injecting and Sexual Behaviors of Male Injecting Drug Users in Kathmandu Valley. Center for Research on Environment Health & Population Activities and FHI (2002)

Injecting and Sexual Behaviors of Male Injecting Drug Users in Kathmandu Valley. Center for Research on Environment Health & Population Activities and FHI (2002) HIV/AIDS has emerged as a prominent health and social concern in Nepal. The recent upsurge of HIV prevalence among IDUs is alarming. Networking and injecting behaviors of IDUs in the Katmandu valley are already identified as very risky but their sexual behavior remains largely unexplored. The study was carried out to obtain detailed and in-depth information about sexual behavior male IDUs in Kathmandu Valley.

Download this publication

National Baseline High Risk and Bridge Population Behavioural Surveillance Survey 2002: Part II- Men who have Sex with Men and Injecting Drug Users. National AIDS Control Organisation India (2002)

National Baseline High Risk and Bridge Population Behavioural Surveillance Survey 2002: Part II- Men who have Sex with Men and Injecting Drug Users. National AIDS Control Organisation India (2002) REPORT
PART II (MEN WHO HAVE SEX WITH MEN AND INJECTING DRUG USERS)
NATIONAL AIDS CONTROL ORGANISATION Ministry of Health & Family Welfare, Government of India, Chandralok Building, 36 Janpath, New Delhi – 110001

Download this publication

Revisiting ‘The Hidden Epidemic’ – A Situation Assessment of Drug Use in Asia in the Context of HIV/AIDS. Unknown Author (2002)

Revisiting ‘The Hidden Epidemic’ – A Situation Assessment of Drug Use in Asia in the Context of HIV/AIDS. Unknown Author (2002) In the nineteenth century opium was a commodity of economic importance and a monopoly and source of revenue which the Cambodian monarch was keen to maintain. Generally Khmer society did not much favour opium and its use was confined to the Chinese business community and foreigners: accounts of opium dens and the ritual use of opium in Phnom Penh at this time exist.

Download this publication

Survey: Behaviorual Surveillance among Drug Injectors in Indonesia, 2002. HIV/AIDS Prevention Project Indonesia (2002)

Survey: Behaviorual Surveillance among Drug Injectors in Indonesia, 2002. HIV/AIDS Prevention Project Indonesia (2002) BSS among men aged 18 years or more who have injected drugs in the last month. Survey was conducted in three large cities: Jakarta, Surabaya, and Bandung. Questions asked cover areas such as: Sexual Activity, Condom Use, Injecting Drug Use, HIV Testing.

Download this publication

HIV and Injecting Drug Use in Selected Sites of the Terai, Nepal. Peak MJ, Rana S and Rai LB (2001)

HIV and Injecting Drug Use in Selected Sites of the Terai, Nepal. Peak MJ, Rana S and Rai LB (2001) During the preparatory visit in December 2000 two regional specific key persons (RSKPs) were identified in Hetauda and Damak to coordinate with the 6 of the 8 locality specific key persons (LSKPs) in the eastern part of Nepal. The methodology undertaken was to conduct two group meetings; one with current injecting drug users and one key stakeholder organizations (government and non governmental sector). With the exception of Kakarbhitta (only IDU group) and Pokhara (extra female IDU group) all groups were convened on time. Representation in each of the groups ranged from 10 to 20 individuals and lasted approximately 2 to 3 hours. The majority of drug use and injecting drug use estimations were derived by nomination techniques and differences were noted according to the key stakeholders and drug user group discussions.

Download this publication

HIV Prevention in Hong Kong Strategy Series: HIV Prevention in Drug Users- Principles of Strategy. AIDS Prevention and Care Committee and Hong Kong Advisory Council on AIDS (2001)

HIV Prevention in Hong Kong Strategy Series: HIV Prevention in Drug Users- Principles of Strategy. AIDS Prevention and Care Committee and Hong Kong Advisory Council on AIDS (2001) The importance of injecting drug use as a route of HIV transmission is well- recognised. Explosive increase in HIV infection among drug users has been continuously reported in several regions, including the southern provinces of Mainland China bordering Hong Kong, and other countries of South-East Asia. Due to a number of factors, such as the wide availability of different modalities of out- patient and residential treatment programmes and the easy access to disposable syringes as well as early intervention since the discovery of the first HIV positive case in 1985, Hong Kong is fortunate enough to have enjoyed an exceedingly low HIV rate associated with injecting drug use (IDU) in the past decade and half. However, more recent analysis of epidemeological data collected in 1999 and 2000 have provided a signal of alarm, calling for reexamination of our strategies of prevention and intervention.

Download this publication

Injecting Drug Users and HIV/AIDS: Information Needs and Research Methods. Jenkins, C (2001)

Injecting Drug Users and HIV/AIDS: Information Needs and Research Methods. Jenkins, C (2001) Injecting drug use is one of the major factors in the increasing spread of HIV today in the Asian region, as well as the Middle East, South America, and in the CIS. There are many gaps in available information needed to guide a comprehensive response to the needs of IDUs, in general, and to the growing HIV epidemic among IDUs in particular.

Download this publication

Structural Determinants of Youth Drug Use. Spooner C, Hall W and Lynskey M (2001)

Structural Determinants of Youth Drug Use. Spooner C, Hall W and Lynskey M (2001) This report was commissioned by the Aus- tralian National Council on Drugs and summarises the available literature on the structural determinants of youth drug use. The breadth of information that could potentially be incorporated in this report is enormous, including literature from the fields of health (public health, child and adolescent development, mental health), economics, crime prevention, social policy and town planning.

Download this publication

Pages

database
Highlighted publications
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Annual_report_2016-17.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_Estimations_and_projections_of_HIV_AIDS_at_Sub-national_level_2016-2020.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_What_New_in_Treatment_Monitoring_Viral_Load_and_CD4_Testing_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_IBBS_2016-17.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_Mapping_Key_Populations_2015-16.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017_Data_2017_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_2017_Global_AIDS_Monitoring_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal-IBBS-FIDU-Kathmandu-valley-RI-2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_Size_Estimation_of_Key_Affected_Populations_in_Philippines.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Assessment_of_Decentralization_of_ART_in_MMR_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-2016-prevention-gap-report_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Biomedical_AIDS_research_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Implementing_comprehensive_HIV_and_STI_programmes_with_transgender_people_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_cities_ending_the_aids_epidemic_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Philippines_2015_IHBSS_Fact_Sheets_Nov2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Integrating_collaborative_TB_and_HIV_services_within_a_comprehensive_package_of_care_for_PWID_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
Calendar of events
Dec
17
Mar
1
(1 Mar - 1 Mar)
Mar
3